Genome-wide significant regions in 43 Utah high-risk families implicate multiple genes involved in risk for completed suicide

Molecular Psychiatry

Volumn 25, Issue 11, 2020, Pages 3077-3090

  Coon, Hilary ^a   Darlington, Todd M ^a   DiBlasi, Emily ^a   Callor, W Brandon ^b   Ferris, Elliott ^a   Fraser, Alison ^a   Yu, Zhe ^a   William, Nancy ^a   Das, Sujan C ^a   Crowell, Sheila E ^c   Chen, Danli ^a   Anderson, John S ^a   Klein, Michael ^c   Jerominski, Leslie ^a   Cannon, Dale ^a   Shabalin, Andrey ^a   Docherty, Anna ^a   Williams, Megan ^a   Smith, Ken R ^a   Keeshin, Brooks ^d   Bakian, Amanda V ^a   Christensen, Erik ^b   Li, Qingqin S ^e   Camp, Nicola J ^a   Gray, Douglas ^a   more..

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Office of the Medical Examiner   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d INTERMOUNTAIN HEALTHCARE   (United States)

^e JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; DNA DETERMINATION; FAMILY HEALTH; FEMALE; GENETIC RISK; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HIGH RISK POPULATION; HUMAN; MALE; MEDICAL RECORD; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SUICIDE; UTAH; ADULT; GENETIC PREDISPOSITION; GENETICS;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; SUICIDE, COMPLETED; UTAH;

EID: 85055493612     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/s41380-018-0282-3     Document Type: Article

References (76)

1. Centers for Disease Control & Prevention (CDC) Data & Statistics Fatal Injury Report for 2015. https://webappa.cdc.gov/sasweb/ncipc/mortrate.html.
2. Pedersen NL, Fiske A. Genetic influences on suicide and nonfatal suicidal behavior: twin study findings. Eur Psychiatry. 2010;25:264–7.
3. McGuffin P, Marusic A, Farmer A. What can psychiatric genetics offer suicidology? Crisis. 2001;22:61–65.
4. Mirkovic B, Laurent C, Podlipski M-A, Frebourg T, Cohen D, Gerardin P. Genetic association studies of suicidal behavior: a review of the past 10 years, progress, limitations, and future directions. Front. Psychiatry 2016;7:158.
5. Younes N, Melchior M, Turbelin C, Blanchon T, Hanslik T, Chan Chee C. Attempted and completed suicide in primary care: not what we expected? J Affect Disord. 2015;170:150–4.
6. Groden J, Thliveris a, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66:589–600.
7. Goldgar DE, Cannon-Albright La, Oliphant a, Ward JH, Linker G, Swensen J, et al. Chromosome 17q linkage studies of 18 Utah breast cancer kindreds. Am J Hum Genet. 1993;52:743–8.
8. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795–803.
9. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry. 2004;4:37.
10. Brezo J, Paris J, Tremblay R, Vitaro F, Hébert M, Turecki G. Identifying correlates of suicide attempts in suicidal ideators: a population-based study. Psychol Med. 2007;37:1551–62.
11. McGirr A, Alda M, Séguin M, Cabot S, Lesage A, Turecki G. Familial aggregation of suicide explained by cluster B traits: A three-group family study of suicide controlling for major depressive disorder. Am J Psychiatry. 2009;166:1124–34.
12. Kim CD, Seguin M, Therrien N, Riopel G, Chawky N, Lesage AD, et al. Familial aggregation of suicidal behavior: A family study of male suicide completers from the general population. Am J Psychiatry. 2005;162:1017–9.
13. Brent DA, Oquendo M, Birmaher B, Greenhill L, Kolko D, Stanley B, et al. Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters. Arch Gen Psychiatry. 2002;59:801–7.
14. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. JAMA J Am Med Assoc. 1985;254:915–8.
15. Geschwind DH, Flint J. Genetics and genomics of psychiatric disease. Science. 2015;349:1489–94.
16. Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.
17. Kerber RA. Method for calculating risk associated with family history of a disease. Genet Epidemiol. 1995;12:291–301.
18. Waller RG, Darlington TM, Wei X, Madsen MJ, Thomas A, Curtin K et al. Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk. PLoS Genet. 2018;14:e1007111.
19. Knight S, Abo RP, Abel HJ, Neklason DW, Tuohy TM, Burt RW, et al. Shared genomic segment analysis: the power to find rare disease variants. Ann Hum Genet. 2012;76:500–9.
20. Fisher R. Statistical methods for research workers. Oliver & Boyd: Edinburgh;1925.
21. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495–501.
22. Fuentes Fajardo KV, Adams D, Mason CE, Sincan M, Tifft C, Toro C, et al. Detecting false-positive signals in exome sequencing. Hum Mutat. 2012;33:609–13.
23. Piñero J, Bravo Á, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45:D833–D839.
24. Piñero J, Queralt-Rosinach N, Bravo À, Deu-Pons J, Bauer-Mehren A, Baron M et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database. 2015;2015:bav028.
25. Leu J, Chang S, Mu C, Chen M, Yan B. Functional domains of SP110 that modulate its transcriptional regulatory function and cellular translocation. J Biomed Sci. 2018;25:34.
26. Boyle EA, Li YI, Pritchard JK. An expanded view of complex traits: from polygenic to omnigenic. Cell. 2017;169:1177–86.
27. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.
28. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–82.
29. Ezkurdia I, Juan D, Rodriguez JM, Frankish A, Diekhans M, Harrow J, et al. Multiple evidence strands suggest that theremay be as few as 19 000 human protein-coding genes. Hum Mol Genet. 2014;23:5866–78.
30. Brundin L, Bryleva EY, Thirtamara Rajamani K. Role of inflammation in suicide: from mechanisms to treatment. Neuropsychopharmacology. 2017;42:271–83.
31. Marquardsen FA, Baldin F, Wunderer F, Al-Herz W, Mikhael R, Lefranc G, et al. Detection of Sp110 by flow cytometry and application to screening patients for veno-occlusive disease with immunodeficiency. J Clin Immunol. 2017;37:707–14.
32. Cai L, Wang Y, Wang J-F, Chou K-C. Identification of proteins interacting with human SP110 during the process of viral infections. Med Chem (Los Angel). 2011;7:121–6.
33. Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Coban Akdemir Z, et al. Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease. Neuron. 2015;88:499–513.
34. Völgyi K, Gulyássy P, Háden K, Kis V, Badics K, Kékesi KA, et al. Synaptic mitochondria: a brain mitochondria cluster with a specific proteome. J Proteom. 2015;120:142–57.
35. Kious BM, Kondo DG, Renshaw PF. Living high and feeling low: altitude, suicide, and depression. Harv Rev Psychiatry. 2018;26:43–56.
36. Haghighi F, Xin Y, Chanrion B, O’Donnell AH, Ge Y, Dwork AJ, et al. Increased DNA methylation in the suicide brain. Dialog Clin Neurosci. 2014;16:430–8.
37. Bekris LM, Tsuang DW, Peskind ER, Yu CE, Montine TJ, Zhang J, et al. Cerebrospinal fluid Abeta42 levels and APP processing pathway genes in Parkinson’s disease. Mov Disord. 2015;30:936–44.
38. Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, et al. A genome-wide association study of suicidal behavior. Am J Med Genet Part B Neuropsychiatr Genet. 2015;168:557–63.
39. Casado PL, Aguiar DP, Costa LC, Fonseca MA, Vieira TCS, Alvim-Pereira CCK et al. Different contribution of BRINP3 gene in chronic periodontitis and peri-implantitis: a cross-sectional study. BMC Oral Health. 2015;15:33.
40. Smith PJ, Levine AP, Dunne J, Guilhamon P, Turmaine M, Sewell GW, et al. Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis. Inflamm Bowel Dis. 2014;20:1802–12.
41. Schosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY et al. Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS ONE 2011;6:e20690.
42. Xie Z, Chan EC, Druey KM. R4 regulator of G protein signaling (RGS) proteins in inflammation and immunity. AAPS J. 2016;18:294–304.
43. Jiménez E, Arias B, Mitjans M, Goikolea JM, Roda E, Sáiz PA, et al. Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients. Eur Neuropsychopharmacol. 2013;23:1452–62.
44. Lindén M, Ramírez Sepúlveda JI, James T, Thorlacius GE, Brauner S, Gómez-Cabrero D et al. Sex influences eQTL effects of SLE and Sjögren’s syndrome-associated genetic polymorphisms. Biol Sex Differ. 2017;8:34.
45. Fiori LM, Turecki G. Broadening our horizons: Gene expression profiling to help better understand the neurobiology of suicide and depression. Neurobiol Dis. 2012;45:14–22.
46. Xu FF, Huang Y, Wang XQ, Qiu YH, Peng YP. Modulation of immune function by glutamatergic neurons in the cerebellar interposed nucleus via hypothalamic and sympathetic pathways. Brain Behav Immun. 2014;38:263–71.
47. Hoyo-Becerra C, Huebener A, Trippler M, Lutterbeck M, Liu ZJ, Truebner K et al. Concomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons. PLoS ONE. 2013;8:e83149.
48. Liu Y, Ramot Y, Torrelo A, Paller AS, Si N, Babay S, et al. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum. 2012;64:895–907.
49. Chmielewski S, Piaszyk-Borychowska A, Wesoly J, Bluyssen HAR. STAT1 and IRF8 in vascular inflammation and cardiovascular disease: diagnostic and therapeutic potential. Int Rev Immunol. 2018;35:434–54.
50. Chen Z, Guo Z, Ma J, Liu F, Gao C, Liu S, et al. STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia. Autoimmunity. 2015;48:305–12.
51. Zimmerman O, Rosen LB, Swamydas M, Ferre EMN, Natarajan M, van de Veerdonk F et al. Autoimmune regulator deficiency results in a decrease in STAT1 levels in human monocytes. Front Immunol 2017;8:820.
52. Giegling I, Calati R, Porcelli S, Hartmann AM, Möller HJ, De Ronchi D, et al. NCAM1, TACR1 and NOS genes and temperament: a study on suicide attempters and controls. Neuropsychobiology. 2011;64:32–37.
53. Kanwar JR, Kanwar RK, Burrow H, Baratchi S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem. 2009;16:2373–94.
54. Choi K, Le T, Xing G, Johnson LR, Ursano RJ. Analysis of kinase gene expression in the frontal cortex of suicide victims: implications of fear and stress†. Front Behav Neurosci 2011;5:46.
55. Quintanilla RA, Orellana DI, González-Billault C, Maccioni RB. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res. 2004;295:245–57.
56. Tombácz D, Maróti Z, Kalmár T, Csabai Z, Balázs Z, Takahashi S, et al. High-coverage whole-exome sequencing identifies candidate genes for suicide in victims with major depressive disorder. Sci Rep. 2017;7:1–11.
57. Gao L, Emond MJ, Louie T, Cheadle C, Berger AE, Rafaels N, et al. Identification of rare variants in ATP8B4 as a risk factor for systemic sclerosis by whole-exome sequencing. Arthritis Rheumatol. 2016;68:191–200.
58. Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, et al. Precision medicine for suicidality: From universality to subtypes and personalization. Mol Psychiatry. 2017;22:1250–73.
59. Menke A, Domschke K, Czamara D, Klengel T, Hennings J, Lucae S, et al. Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmacology. 2012;37:797–807.
60. Li K, Zhang Y, Liang KY, Xu S, Zhou XJ, Tan K et al. Rheb1 deletion in myeloid cells aggravates OVA-induced allergic inflammation in mice. Sci Rep. 2017;7:42655.
61. Shen C, Liu L, Jiang Z, Zheng X, Meng L, Yin X, et al. Four genetic variants interact to confer susceptibility to atopic dermatitis in Chinese Han population. Mol Genet Genom. 2015;290:1493–8.
62. Kékesi KA, Juhász G, Simor A, Gulyássy P, Szego ÉM, Hunyadi-Gulyás É et al. Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide. PLoS ONE. 2012;7:e50532.
63. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010;233:34–54.
64. Perin P, Potočnik U. Polymorphisms in recent GWA identified asthma genes CA10, SGK493, and CTNNA3 are associated with disease severity and treatment response in childhood asthma. Immunogenetics. 2014;66:143–51.
65. Flory JD, Donohue D, Muhie S, Yang R, Miller SA, Hammamieh R et al. Gene expression associated with suicide attempts in US veterans. Transl Psychiatry. 2017;7:e1226.
66. Katoh M, Katoh M. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review). Int J Mol Med. 2007;19:273–8.
67. Bani-Fatemi A, Howe AS, Matmari M, Koga A, Zai C, Strauss J, et al. Interaction between methylation and CpG single-nucleotide polymorphisms in the HTR2A gene: association analysis with suicide attempt in schizophrenia. Neuropsychobiology. 2016;73:10–15.
68. González-Castro TB, Tovilla-Zárate C, Juárez-Rojop I, Pool García S, Velázquez-Sánchez MP, Genis A et al. Association of the 5HTR2A gene with suicidal behavior: case-control study and updated meta-analysis. BMC Psychiatry 2013;13:25.
69. Garbett K, Gal-Chis R, Gaszner G, Lewis DA, Mirnics K. Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide. Neuropsychopharmacol Hung. 2008;10:9–14.
70. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS ONE 2012;7:e35367.
71. Mann JJ, Stanley M, McBride PA, McEwen BS. Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 1986;43:954–9.
72. Antypa N, Serretti A, Rujescu D. Serotonergic genes and suicide: a systematic review. Eur Neuropsychopharmacol. 2013;23:1125–42.
73. Mandelli L, Serretti A. Gene environment interaction studies in depression and suicidal behavior: an update. Neurosci Biobehav Rev. 2013;37:2375–97.
74. Schild AHE, Pietschnig J, Tran US, Voracek M. Genetic association studies between SNPs and suicidal behavior: a meta-analytical field synopsis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;46:36–42.
75. Idzko M, Panther E, Stratz C, Müller T, Bayer H, Zissel G, et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol. 2004;172:6011–9.
76. Takata Y, Hamada D, Miyatake K, Nakano S, Shinomiya F, Scafe CR, et al. Genetic association between the PRKCH gene encoding protein kinase Ceta isozyme and rheumatoid arthritis in the Japanese population. Arthritis Rheum. 2007;56:30–42.